Vivonics Inc.

03/31/2025

🌀 Have Meniere’s Disease or treat patients who do? We want to hear from you!

Vivonics Inc. is conducting a NIH-funded research study to better understand the experiences of people living with Meniere’s Disease—and the healthcare providers who care for them. Your insights will help shape the development of a new medical device designed to safely reduce dizziness during vertigo episodes.

🗣️ Who we’re looking for:
✔️ Patients diagnosed with Meniere’s Disease
✔️ Healthcare providers experienced in treating Meniere’s

📅 Participate in a brief 30–45 min virtual interview with our team.
👉 Visit: www.surveymonkey.com/r/XHGZX8H to see if you qualify.

Your voice matters. Your story can help drive innovation.
All responses are private and confidential.

09/05/2024

Vivonics is excited to announce that we have been awarded a $319,000 grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) for Phase I development of our Galvanic Vestibular Stimulation (GVS) technology to treat the symptoms of Ménière's disease, led jointly by our CEO Gordon Hirschman and Devin McCaslin, Ph.D. of the University of Michigan, with key support from Mindy Bishop, Ph.D. at Vivonics. Ménière's disease is a debilitating illness characterized by episodic attacks of vertigo, which can make many activities of daily living dangerous or impossible. GVS is an innovative technology that allows for treatment of vertigo and balance issues by applying electricity via the skin to the vestibular system, a key component of balance in humans. Vivonics has been developing GVS technology over the past decade for many different applications to explore new ways of treating these conditions without pharmaceuticals or invasive implants, and this project is the latest extension of that work. An important part of this program will include a human study in collaboration with Dr. McCaslin to demonstrate the effectiveness of the system. With this technology, sufferers of Ménière's disease will have a new way of treating their symptoms without the side effects of drugs or other conventional methods, allowing them to resume their normal lives in safety and comfort.

Thanks to everyone at Vivonics for making this happen!

09/04/2024

Michaelina Dupnik and Joshua Colls recently presented on behalf of Vivonics at the 2024 Military Health System Research Symposium (MHSRS) in Kissimmee, FL. Further information on the conference, as well as the posters presented, can be found on our website below.

Michaelina Dupnik and Joshua Colls recently presented on behalf of Vivonics at the 2024 Military Health System Research Symposium (MHSRS) in Kissimmee, FL. MHSRS is an annual scientific conference and educational symposium run by the Department of Defense for presenting scientific knowledge on milit

08/13/2024

Vivonics is pleased to announce that we have been awarded a $197,000 contract from the U.S. Department of Defense Chemical and Biological Defense Program for Phase I development of our Continuous Thermal Strain Monitoring and Prevention (CTS-MAP) system, spearheaded by Dr. Michele Pierro. Military servicemembers often need to wear heavy protective gear in hazardous environments, which puts them at risk for heat stress and heatstroke. To prevent this, the military utilizes personal cooling systems; however, for the cooling systems to be used optimally and power consumption to be minimized, a method is needed to detect the onset of heat stress so cooling can be activated only when needed. CTS-MAP uses a novel optical approach to identify key markers of early heat stress in servicemembers, ensuring that they can be provided with optimal personal cooling to preserve their health, safety, and effectiveness.

Thanks to the entire Vivonics team for making this happen!

05/27/2024

On this Memorial Day, we remember and honor the men and women of the Armed Forces who gave their lives in the service of their country. Vivonics is dedicated to the development of novel medical technology for the United States military in the hopes that with it, the lives of injured servicemembers can be saved and they have the best care possible so they can return home to continue to live long, productive lives.

04/11/2024

Meet Vivonics Founder and CEO Gordon Hirschman at the NextFlex Workshop "Advancing Electronics Packaging of Hybrid Electronics for Industrial and Medical Applications" at Binghamton University next week on April 18th!

This event is open to everyone.

03/29/2024

Vivonics is excited to announce that we have been awarded a $1.3 million sequential (second) Phase II SBIR contract from the United States Army Medical Research Acquisition Activity (USAMRAA) for continued development of our Vestibular Intervention via Portable Electrical Stimulator (VIPES) system. An impaired vestibular system is a hallmark of acute traumatic brain injury (TBI) and causes considerable long-term deficits in quality of life, including dizziness and loss of balance. Headed by Ms. Michaelina Dupnik, the VIPES project aims to create a wearable system that uses electrical stimulation of the vestibular system to correct balance disorders, allowing patients to resume normal activities of daily living. This award will allow us to test VIPES in a pilot clinical trial, advancing the device further toward commercialization, where it can improve the quality of life in military and civilian populations alike.

Thanks to the Vivonics team for making this happen!